2/27
07:03 pm
sndx
Syndax Pharmaceuticals Inc (SNDX) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
Low
Report
Syndax Pharmaceuticals Inc (SNDX) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
2/27
06:00 pm
sndx
Syndax Pharmaceuticals (SNDX) was given a new $45.00 price target by Stifel Nicolaus.
Low
Report
Syndax Pharmaceuticals (SNDX) was given a new $45.00 price target by Stifel Nicolaus.
2/26
04:22 pm
sndx
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
04:01 pm
sndx
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/23
07:00 am
sndx
Syndax Announces Participation in March Investor Conferences
Neutral
Report
Syndax Announces Participation in March Investor Conferences
2/19
07:00 am
sndx
Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026
Low
Report
Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026
2/15
09:32 pm
sndx
Is Syndax Pharmaceuticals (SNDX) Pricing Reflecting Recent Biotech Reassessment Or Long Term Potential [Yahoo! Finance]
Low
Report
Is Syndax Pharmaceuticals (SNDX) Pricing Reflecting Recent Biotech Reassessment Or Long Term Potential [Yahoo! Finance]
2/12
05:56 am
sndx
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 [Seeking Alpha]
Low
Report
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 [Seeking Alpha]
2/7
02:07 am
sndx
Syndax Pharmaceuticals (NASDAQ:SNDX) was upgraded by analysts at
Wall St
Low
Report
Syndax Pharmaceuticals (NASDAQ:SNDX) was upgraded by analysts at
Wall St
2/5
07:00 am
sndx
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit
Low
Report
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit
2/4
04:01 pm
sndx
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
1/27
11:45 am
sndx
Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target raised by analysts at Mizuho from $410.00 to $600.00. They now have an "outperform" rating on the stock.
Low
Report
Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target raised by analysts at Mizuho from $410.00 to $600.00. They now have an "outperform" rating on the stock.
1/19
05:21 pm
sndx
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory [Yahoo! Finance]
1/12
08:55 am
sndx
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/12
07:00 am
sndx
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
1/11
01:03 am
sndx
Syndax Pharmaceuticals (NASDAQ:SNDX) was downgraded by analysts at
Wall
Low
Report
Syndax Pharmaceuticals (NASDAQ:SNDX) was downgraded by analysts at
Wall
1/7
07:00 am
sndx
Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.
Medium
Report
Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.
1/5
07:00 am
sndx
Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
1/3
01:08 am
sndx
Syndax Pharmaceuticals (NASDAQ:SNDX) was upgraded by analysts at
Wall St
Medium
Report
Syndax Pharmaceuticals (NASDAQ:SNDX) was upgraded by analysts at
Wall St
12/17
08:17 am
sndx
Syndax Pharma: Continuing Execution In AML [Seeking Alpha]
Low
Report
Syndax Pharma: Continuing Execution In AML [Seeking Alpha]
12/12
07:00 am
sndx
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
Low
Report
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
12/9
08:07 am
sndx
Syndax Pharmaceuticals (NASDAQ:SNDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $56.00 price target on the stock.
Medium
Report
Syndax Pharmaceuticals (NASDAQ:SNDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $56.00 price target on the stock.
12/8
06:50 am
sndx
Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum
Medium
Report
Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum
12/3
04:01 pm
sndx
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/1
07:13 am
sndx
Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Medium
Report
Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]